DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- EBITDA, 2025
- $2.1B
- YoY, 2025
- +15.6%
- 5-year CAGR
- −1.8%
- 10-year CAGR
- +2.2%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $2.1B | +15.6% |
| 2024 | $1.8B | +8.1% |
| 2023 | $1.7B | −8.8% |
| 2022 | $1.9B | −33.1% |
| 2021 | $2.8B | +19.6% |
| 2020 | $2.3B | +49.5% |
| 2019 | $1.6B | +10.6% |
| 2018 | $1.4B | −1.7% |
| 2017 | $1.4B | −6.0% |
| 2016 | $1.5B | −10.4% |
| 2015 | $1.7B | +31.3% |
| 2014 | $1.3B | −26.2% |
| 2013 | $1.8B | +18.1% |
| 2012 | $1.5B | +17.4% |
| 2011 | $1.3B | −17.5% |
| 2010 | $1.5B | −4.8% |
| 2009 | $1.6B | +8.7% |
| 2008 | $1.5B | +11.9% |
| 2007 | $1.3B | — |